CD4 and lung carcinoma: Inhibitory receptors TIM-3, LAG-3, CTLA-4 and PD-L1 are also expressed on MPE CD4+ and CD8+ T cells at greater proportions than matched peripheral blood samples in mesothelioma and lung cancer patients (56, 62, 63, 67, 69).